In support of a liver-specific cytostatic response and shared fibrogenic response, Smad4 reactivation reduced the proportion of Ki67+ tumor cells only in the liver, while both the liver and lungs exhibited increases in α-SMA levels (Fig. 3c,d). The gene discussed is MKI67; the disease is neoplasm.